For the Inventor, By the Inventor

Enter assignee name

Mississauga, Canada

Nps Allelix Corporation

USPTO Granted Patents = 38

% Expired Patents = 26.3

CIPO Patents = 1

Forward Citations = 224

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Rajender Kamboj (17 out of 33 patents)

Candace E Elliott (12 out of 19 patents)

Stephen L Nutt (12 out of 25 patents)

4. Abdelmalik Slassi (10 out of 59 patents)

5. Ashok Tehim (9 out of 71 patents)

6. Tao Xin (9 out of 29 patents)

7. Louise G Edwards (7 out of 37 patents)

8. Methvin Benjamin Isaac (5 out of 36 patents)

9. John Dietrich (3 out of 6 patents)

10. Sverker Ljunghall (3 out of 6 patents)

11. Donald G Munroe (3 out of 8 patents)

12. Ashwani K Gupta (3 out of 7 patents)

13. Ian Egle (3 out of 16 patents)

14. Jalaj Arora (3 out of 9 patents)

15. Jennifer Frey (3 out of 3 patents)

Core Competencies:

Bone Resorption

Serotonin Receptor

AMPA Receptors

Glucagon-like Peptide

EDG Receptors

Kainate Receptors

Migraine Treatment

Parathyroid Hormone

Azaindoles

Bicyclic Compounds

CNS Receptors

38 patents: Sort by Forward Citations

1. 7507715 - Methods useful in the treatment of bone resorption diseases (2009-03-24),

2. 7268127 - Azaindoles having serotonin receptor affinity (2007-09-11),

3. 7071306 - AMPA-binding human GluR4 receptors (2006-07-04),

4. 7056886 - GLP-2 formulations (2006-06-06),

5. 7052850 - Isolated human EDG-4 receptor (2006-05-30),

6. 7030221 - AMPA-binding human GluR3 receptors (2006-04-18),

7. 7018982 - Methods useful in the treatment of bone resorption diseases (2006-03-28),

8. 6962796 - Production of human parathyroid hormone from microorganisms (2005-11-08),

9. 6916818 - Azaindoles having serotonin receptor affinity (2005-07-12),

10. 6897215 - Compounds having 5-HT6 receptor antagonist activity (2005-05-24),

11. 6686374 - Azaindoles having serotonin receptor affinity (2004-02-03),

12. 6635639 - Use of N-alkylamino-heterocylic compounds for the treatment of migraine (2003-10-21),

13. 6579987 - Diaryl-enynes (2003-06-17),

14. 6566096 - Mammalian EDG-7 receptor homologs (2003-05-20),

15. 6562809 - 3-bicycloindole compounds (2003-05-13),

Company Overview

Nps Allelix Corporation, based in Mississauga, Canada, is engaged in the development and commercialization of innovative biopharmaceuticals. The company specializes in advanced therapeutic solutions, focusing on areas such as oncology and autoimmune diseases. With a commitment to research and development, Nps Allelix leverages cutting-edge technology to create effective treatments that address unmet medical needs, aiming to improve patient outcomes and enhance quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

38 Patents

#26 in Mississauga

#357 in Canada

#17,860 in the World

Mississauga, Canada

Nps Allelix Corporation

Forward Citations = 224

38 inventors:

Rajender Kamboj (17 out of 33 patents)

Candace E Elliott (12 out of 19 patents)

Stephen L Nutt (12 out of 25 patents)

4. Abdelmalik Slassi (10 out of 59 patents)

5. Ashok Tehim (9 out of 71 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nps Allelix Corporation. Retrieved from https://idiyas.com/company/nps-allelix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…